Fred Alger Management’s Boston Scientific BSX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $91.3M | Buy |
1,454,619
+357,944
| +33% | +$28.6M | 0.4% | 40 |
|
|
2025
Q4 | $105M | Buy |
1,096,675
+110,728
| +11% | +$10.9M | 0.41% | 37 |
|
|
2025
Q3 | $96.3M | Sell |
985,947
-2,022
| -0.2% | -$209K | 0.37% | 35 |
|
|
2025
Q2 | $106M | Buy |
987,969
+12,366
| +1% | +$1.25M | 0.48% | 33 |
|
|
2025
Q1 | $98.4M | Sell |
975,603
-397,418
| -29% | -$40M | 0.56% | 28 |
|
|
2024
Q4 | $123M | Sell |
1,373,021
-415,971
| -23% | -$36.6M | 0.58% | 29 |
|
|
2024
Q3 | $150M | Sell |
1,788,992
-245,570
| -12% | -$19.4M | 0.73% | 27 |
|
|
2024
Q2 | $157M | Sell |
2,034,562
-173,087
| -8% | -$12.7M | 0.76% | 25 |
|
|
2024
Q1 | $151M | Sell |
2,207,649
-12,045
| -0.5% | -$774K | 0.75% | 27 |
|
|
2023
Q4 | $128M | Sell |
2,219,694
-376,778
| -15% | -$20.1M | 0.69% | 30 |
|
|
2023
Q3 | $137M | Buy |
2,596,472
+537,992
| +26% | +$28.2M | 0.79% | 22 |
|
|
2023
Q2 | $111M | Buy |
2,058,480
+58,323
| +3% | +$3.05M | 0.57% | 43 |
|
|
2023
Q1 | $100M | Buy |
2,000,157
+813,771
| +69% | +$38.4M | 0.54% | 50 |
|
|
2022
Q4 | $54.9M | Buy |
+1,186,386
| New | +$51.4M | 0.3% | 100 |
|
|
2021
Q3 | – | Sell |
-122,606
| Closed | -$5.24M | – | 518 |
|
|
2021
Q2 | $5.24M | Sell |
122,606
-332,519
| -73% | -$14M | 0.01% | 292 |
|
|
2021
Q1 | $17.6M | Buy |
455,125
+67,644
| +17% | +$2.56M | 0.05% | 211 |
|
|
2020
Q4 | $13.9M | Sell |
387,481
-9,447,559
| -96% | -$341M | 0.04% | 215 |
|
|
2020
Q3 | $376M | Sell |
9,835,040
-15,751
| -0.2% | -$607K | 1.09% | 17 |
|
|
2020
Q2 | $346M | Buy |
9,850,791
+828,880
| +9% | +$29.9M | 1.14% | 18 |
|
|
2020
Q1 | $294M | Buy |
9,021,911
+1,073,710
| +14% | +$41.9M | 1.29% | 15 |
|
|
2019
Q4 | $359M | Sell |
7,948,201
-2,153,158
| -21% | -$90.1M | 1.32% | 13 |
|
|
2019
Q3 | $411M | Sell |
10,101,359
-293,251
| -3% | -$12.4M | 1.61% | 12 |
|
|
2019
Q2 | $447M | Buy |
10,394,610
+368,412
| +4% | +$14.2M | 1.72% | 11 |
|
|
2019
Q1 | $385M | Sell |
10,026,198
-3,222,479
| -24% | -$123M | 1.53% | 14 |
|
|
2018
Q4 | $468M | Buy |
13,248,677
+5,179,308
| +64% | +$188M | 2.16% | 9 |
|
|
2018
Q3 | $311M | Buy |
8,069,369
+2,329,670
| +41% | +$81.4M | 1.17% | 18 |
|
|
2018
Q2 | $188M | Buy |
5,739,699
+888,982
| +18% | +$26.8M | 0.79% | 30 |
|
|
2018
Q1 | $133M | Buy |
4,850,717
+1,631,130
| +51% | +$44.3M | 0.62% | 38 |
|
|
2017
Q4 | $79.8M | Sell |
3,219,587
-1,523,073
| -32% | -$42M | 0.36% | 73 |
|
|
2017
Q3 | $138M | Buy |
4,742,660
+1,401,492
| +42% | +$38.7M | 0.65% | 38 |
|
|
2017
Q2 | $92.6M | Buy |
3,341,168
+828,137
| +33% | +$22M | 0.44% | 60 |
|
|
2017
Q1 | $62.5M | Sell |
2,513,031
-801,815
| -24% | -$19.5M | 0.31% | 79 |
|
|
2016
Q4 | $71.7M | Sell |
3,314,846
-1,140,836
| -26% | -$24.9M | 0.39% | 64 |
|
|
2016
Q3 | $106M | Buy |
4,455,682
+559,076
| +14% | +$13.3M | 0.54% | 48 |
|
|
2016
Q2 | $91.1M | Sell |
3,896,606
-145,013
| -4% | -$3.14M | 0.48% | 56 |
|
|
2016
Q1 | $76M | Buy |
4,041,619
+3,651,019
| +935% | +$64.1M | 0.39% | 68 |
|
|
2015
Q4 | $7.2M | Buy |
+390,600
| New | +$7M | 0.04% | 215 |
|
|
2014
Q4 | – | Sell |
-292
| Closed | -$3K | – | 582 |
|
|
2014
Q3 | $3K | Hold |
292
| – | – | ﹤0.01% | 574 |
|
|
2014
Q2 | $4K | Hold |
292
| – | – | ﹤0.01% | 590 |
|
|
2014
Q1 | $4K | Hold |
292
| – | – | ﹤0.01% | 565 |
|
|
2013
Q4 | $4K | Buy |
+292
| New | +$3.45K | ﹤0.01% | 545 |
|
Other funds holding BSX
VCM
VPM
Fred Alger Management's BSX Position: Q1 2026 in Review
Fred Alger Management increased its Boston Scientific (BSX) stake by 33% in Q1 2026, buying an estimated $28.6M and bringing the position to 1,454,619 shares worth $91.3M. The position accounts for 0.4% of the portfolio, ranked #40.
Fred Alger Management first reported a position in BSX in Q4 2013 and has held it in 41 quarters since. The position peaked at $468M in Q4 2018. 1,664 funds tracked by Wall St. Rank hold BSX as of Q1 2026.
- Fred Alger Management held 1,454,619 shares of Boston Scientific worth $91.3M as of Q1 2026.
- Fred Alger Management bought 357,944 Boston Scientific shares in Q1 2026, an estimated $28.6M.
- Boston Scientific made up 0.4% of Fred Alger Management's portfolio in Q1 2026, its #40 holding.
- Fred Alger Management first reported a position in Boston Scientific in Q4 2013 and has held it in 41 quarters since.
- Fred Alger Management's Boston Scientific position peaked at $468M in Q4 2018.
- 1,664 funds tracked by Wall St. Rank held Boston Scientific as of Q1 2026.
Based on Fred Alger Management's 13F filing for Q1 2026, filed 15 May 2026.